These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 2139770

  • 1. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
    el Hag IA, Roos G, Jönsson PE, Stenram U.
    Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
    [Abstract] [Full Text] [Related]

  • 2. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
    Jakobsson B, el Hag IA, Erichsen C, Christensson PI, Jönsson PE, Stenram U.
    Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M, Yamaizumi Z, Nakajima Y, Nishimura S, Hoshi A.
    Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
    Ashour OM, Naguib FN, Khalifa MM, Abdel-Raheem MH, Panzica RP, el Kouni MH.
    Cancer Res; 1995 Mar 01; 55(5):1092-8. PubMed ID: 7866994
    [Abstract] [Full Text] [Related]

  • 5. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M, Nishikata K, Hoshi A.
    Jpn J Cancer Res; 1992 Apr 01; 83(4):392-6. PubMed ID: 1387127
    [Abstract] [Full Text] [Related]

  • 6. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M, Hoshi A.
    Cancer Chemother Pharmacol; 1984 Apr 01; 13(2):86-90. PubMed ID: 6235977
    [Abstract] [Full Text] [Related]

  • 7. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL, Fischer PH.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [Abstract] [Full Text] [Related]

  • 8. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A, Keppler D.
    J Natl Cancer Inst; 1986 Mar 01; 76(3):485-92. PubMed ID: 2419623
    [Abstract] [Full Text] [Related]

  • 9. Potentiation by acyclothymidine esters of the antitumor effect of orally administered 5-fluoro-2'-deoxyuridine esters on L1210 in mice.
    Kawaguchi T, Saito M, Saneyoshi M.
    Jpn J Cancer Res; 1986 May 01; 77(5):436-9. PubMed ID: 2942523
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.
    Houghton JA, Houghton PJ, Wooten RS.
    Cancer Res; 1979 Jul 01; 39(7 Pt 1):2406-13. PubMed ID: 156065
    [No Abstract] [Full Text] [Related]

  • 11. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
    Ishiwata K, Ido T, Kawashima K, Murakami M, Takahashi T.
    Eur J Nucl Med; 1984 Jul 01; 9(4):185-9. PubMed ID: 6232143
    [Abstract] [Full Text] [Related]

  • 12. [Studies of the antitumor activity and enzymology of 2'-deoxy-5-fluorouridine (FdUrd) derivatives].
    Fujii S, Shirasaka T.
    Gan No Rinsho; 1986 Apr 01; 32(4):379-82. PubMed ID: 2940387
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
    Iigo M, Nishikata K, Nakajima Y, Szinai I, Veres Z, Szabolcs A, De Clercq E.
    Biochem Pharmacol; 1990 Apr 01; 39(7):1247-53. PubMed ID: 2138895
    [Abstract] [Full Text] [Related]

  • 14. Identification and quantitation of 5-fluorouridine in rat urine after administration of 5-fluorouracil or 5-fluoro-2'-deoxyuridine.
    Gelijkens CF, Sandra P, Belpaire F, De Leenheer AP.
    Drug Metab Dispos; 1980 Apr 01; 8(5):363-6. PubMed ID: 6107236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA, Jakobsson B, Christensson PI, Erichsen C, Jönsson PE, Stenram U.
    In Vivo; 1987 Apr 01; 1(5):309-12. PubMed ID: 2485133
    [Abstract] [Full Text] [Related]

  • 18. Glycosidic bond cleavage of 5-fluoro-2'-deoxyuridine and 5-fluorouridine by amino acyl-tRNA synthetases.
    Kumar AM, Nayak R.
    Biochem Biophys Res Commun; 1990 Dec 14; 173(2):731-5. PubMed ID: 2148086
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
    Sobrero AF, Moir RD, Bertino JR, Handschumacher RE.
    Cancer Res; 1985 Jul 14; 45(7):3155-60. PubMed ID: 3159474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.